Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Jan 2022
Historique:
received: 23 12 2021
revised: 16 01 2022
accepted: 18 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 5 3 2022
Statut: epublish

Résumé

Hereditary pancreatic cancers are caused by several inherited genes. Familial pancreatic cancer is defined as pancreatic cancer arising in a patient with at least two first-degree relatives with pancreatic cancer in the absence of an identified genetic cause. Hereditary pancreatic cancer syndromes and familial pancreatic cancers account for about 10% of pancreatic cancer cases. Germline mutations in

Identifiants

pubmed: 35163129
pii: ijms23031205
doi: 10.3390/ijms23031205
pmc: PMC8835700
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Res. 2008 Jun 15;68(12):4928-35
pubmed: 18544627
J Natl Cancer Inst. 2011 Feb 16;103(4):334-46
pubmed: 21183737
Mol Carcinog. 2012 Jan;51(1):14-24
pubmed: 22162228
Prev Med. 2007 Oct;45(4):313-9
pubmed: 17628652
Cancer Res. 2000 Sep 15;60(18):5037-9
pubmed: 11016625
Gastroenterology. 2019 Feb;156(3):647-661.e2
pubmed: 30342036
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Cancer. 2016 Dec 1;122(23):3673-3681
pubmed: 27496084
Fam Cancer. 2011 Jun;10(2):225-31
pubmed: 21365267
Blood. 2013 May 16;121(20):4036-45
pubmed: 23440242
Genet Med. 2015 Jul;17(7):569-77
pubmed: 25356972
Nature. 1993 Dec 16;366(6456):704-7
pubmed: 8259215
Gastroenterology. 2020 Jul;159(1):358-362
pubmed: 32416142
Nat Rev Cancer. 2017 Apr;17(4):209-222
pubmed: 28233802
Nat Genet. 1998 Jan;18(1):38-43
pubmed: 9425897
Gastroenterology. 2021 May;160(6):2119-2132.e9
pubmed: 33524400
Am J Pathol. 1999 Jun;154(6):1835-40
pubmed: 10362809
Cancer. 2018 Apr 1;124(7):1374-1382
pubmed: 29338080
Nature. 2001 Feb 22;409(6823):1067-70
pubmed: 11234019
J Clin Oncol. 2007 Apr 10;25(11):1417-22
pubmed: 17416862
Clin Gastroenterol Hepatol. 2004 Jul;2(7):606-21
pubmed: 15224285
Br J Cancer. 2009 Nov 17;101(10):1792-7
pubmed: 19826425
Gastroenterology. 2012 Apr;142(4):796-804; quiz e14-5
pubmed: 22245846
EBioMedicine. 2020 Oct;60:103033
pubmed: 32980694
Curr Opin Oncol. 2018 Jan;30(1):23-29
pubmed: 29076966
World J Gastroenterol. 2014 Aug 28;20(32):11182-98
pubmed: 25170203
Am J Epidemiol. 2005 Dec 1;162(11):1123-31
pubmed: 16236996
Oncogene. 2004 Mar 25;23(13):2330-8
pubmed: 14743206
Gastroenterology. 2011 Apr;140(4):1303-1313.e1-3
pubmed: 21199651
Fam Cancer. 2015 Mar;14(1):95-103
pubmed: 25240578
J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
JCO Precis Oncol. 2018;2018:
pubmed: 30051098
Cancer Res. 2004 Apr 1;64(7):2634-8
pubmed: 15059921
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Curr Opin Gastroenterol. 2005 Sep;21(5):544-54
pubmed: 16093768
Am J Gastroenterol. 2018 Sep;113(9):1376
pubmed: 30018304
Cancer Chemother Pharmacol. 2017 Mar;79(3):595-602
pubmed: 28236000
Gastroenterology. 1999 Jul;117(1):7-10
pubmed: 10381903
Genes Cancer. 2011 Apr;2(4):475-84
pubmed: 21779515
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Cancer Res. 2000 Jan 15;60(2):409-16
pubmed: 10667595
Lancet Oncol. 2011 Jan;12(1):49-55
pubmed: 21145788
Int J Cancer. 2010 Sep 1;127(6):1421-8
pubmed: 20049842
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Clin Gastroenterol Hepatol. 2004 Mar;2(3):252-61
pubmed: 15017610
Acta Oncol. 2020 Apr;59(4):417-426
pubmed: 31924107
Nature. 2015 Feb 26;518(7540):495-501
pubmed: 25719666
Gastroenterology. 2014 Mar;146(3):643-646.e8
pubmed: 24333619
JAMA. 2019 Aug 6;322(5):438-444
pubmed: 31386141
Lancet. 1999 Jul 3;354(9172):42-3
pubmed: 10406366
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
JAMA. 2009 Oct 28;302(16):1790-5
pubmed: 19861671
N Engl J Med. 1987 Jun 11;316(24):1511-4
pubmed: 3587280
Nat Rev Cancer. 2012 Dec;12(12):801-17
pubmed: 23175119
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
J Pathol. 2014 Jul;233(3):217-27
pubmed: 24604757
JAMA. 2001 Jul 11;286(2):169-70
pubmed: 11448279
Gastroenterology. 2007 Jul;133(1):48-56
pubmed: 17631130
Am J Gastroenterol. 2009 Sep;104(9):2175-81
pubmed: 19491823
Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G315-9
pubmed: 15246966
Gastroenterology. 2020 Jan;158(1):226-237.e5
pubmed: 31473224
Gut. 2021 Mar;70(3):606-617
pubmed: 32855305
Gastroenterology. 2000 Dec;119(6):1447-53
pubmed: 11113065
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3536-42
pubmed: 19064568
Cancer Cell. 2010 Nov 16;18(5):499-509
pubmed: 21056012
Gut. 1993 Oct;34(10):1394-6
pubmed: 8244108
Cancer. 2002 May 1;94(9):2490-501
pubmed: 12015775
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Int J Cancer. 2000 Sep 15;87(6):809-11
pubmed: 10956390
N Engl J Med. 1991 Dec 26;325(26):1831-6
pubmed: 1961222
Eur J Cancer. 2018 Jan;89:19-26
pubmed: 29223478
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):342-6
pubmed: 17301269
J Surg Oncol. 2019 May;119(6):777-783
pubmed: 30636051
Clin Genet. 2010 Nov;78(5):490-4
pubmed: 20412113
J Clin Oncol. 2019 Feb 1;37(4):286-295
pubmed: 30376427
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Fam Cancer. 2013 Mar;12(1):27-33
pubmed: 22987205
J Clin Oncol. 2015 Jan 20;33(3):244-50
pubmed: 25366685
Nat Genet. 1998 Dec;20(4):398-400
pubmed: 9843217
Gastroenterology. 2011 Mar;140(3):850-6
pubmed: 21129377
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
JAMA. 2018 Jun 19;319(23):2401-2409
pubmed: 29922827
Invest New Drugs. 2018 Oct;36(5):939-948
pubmed: 29572783
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
pubmed: 23628597
J Clin Oncol. 2009 Jan 20;27(3):433-8
pubmed: 19064968
J Clin Oncol. 2021 Aug 1;39(22):2497-2505
pubmed: 33970687
Cancer Treat Rev. 2019 Nov;80:101895
pubmed: 31542591
Cancer. 2018 Apr 15;124(8):1691-1700
pubmed: 29360161
Nat Rev Cancer. 2005 May;5(5):388-96
pubmed: 15864280
N Engl J Med. 1995 Oct 12;333(15):970-4
pubmed: 7666916
Am J Gastroenterol. 2019 Jan;114(1):155-164
pubmed: 30353057
Cancer Biol Ther. 2009 Jan;8(2):131-5
pubmed: 19029836
Ann Oncol. 2019 Jan 1;30(1):44-56
pubmed: 30395155
JAMA Oncol. 2021 May 1;7(5):693-699
pubmed: 33662100
Clin Cancer Res. 2020 Jul 1;26(13):3239-3247
pubmed: 32444418
Gastroenterology. 2019 May;156(6):1905-1913
pubmed: 30716324
Lancet Oncol. 2020 Sep;21(9):1155-1164
pubmed: 32771088
J Natl Cancer Inst. 2003 Feb 5;95(3):214-21
pubmed: 12569143
Fam Cancer. 2009;8(2):109-17
pubmed: 18763055
Ann Surg. 2020 Aug 18;:
pubmed: 32826389
Gut. 2020 Jan;69(1):7-17
pubmed: 31672839
Cancer Prev Res (Phila). 2021 Apr;14(4):433-440
pubmed: 33509806
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
pubmed: 10433620
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1771-7
pubmed: 23897584
Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):493-502
pubmed: 34002083
J Natl Cancer Inst. 2005 Nov 16;97(22):1688-94
pubmed: 16288122
Nature. 2012 Nov 15;491(7424):399-405
pubmed: 23103869
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
Cancer Res. 2002 Jul 1;62(13):3789-93
pubmed: 12097290
Ann Epidemiol. 2003 Oct;13(9 Suppl):S5-17
pubmed: 14575938
Cancer Discov. 2015 Feb;5(2):135-42
pubmed: 25472942
J Med Genet. 2005 Sep;42(9):711-9
pubmed: 16141007
J Natl Cancer Inst. 1997 Mar 19;89(6):442-6
pubmed: 9091646
Fam Cancer. 2011 Jun;10(2):323-30
pubmed: 21207249
Nat Genet. 2017 Oct;49(10):1476-1486
pubmed: 28825726
Am J Gastroenterol. 2010 Sep;105(9):2079-84
pubmed: 20354507
Nat Rev Cancer. 2016 Feb;16(2):110-20
pubmed: 26775620
Am J Pathol. 2001 Dec;159(6):2017-22
pubmed: 11733352
Am J Gastroenterol. 2013 Jun;108(6):1003-9
pubmed: 23458848
Br J Cancer. 2014 Sep 9;111(6):1132-8
pubmed: 25072261
Am J Epidemiol. 2008 Apr 1;167(7):807-13
pubmed: 18263601
Ann Epidemiol. 1994 Jan;4(1):1-10
pubmed: 8205268
Cancer Discov. 2017 Jun;7(6):620-629
pubmed: 28242752
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263
pubmed: 25645574
Int J Cancer. 2005 Mar 20;114(2):323-7
pubmed: 15540225
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947
pubmed: 31648972
Dig Liver Dis. 2013 Jul;45(7):606-11
pubmed: 23415580
Gastroenterology. 2018 Sep;155(3):740-751.e2
pubmed: 29803839
J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65
pubmed: 12237281
Gastroenterology. 2015 Mar;148(3):556-64
pubmed: 25479140
Cancer Res. 2009 Aug 15;69(16):6381-6
pubmed: 19654294
Cancer Discov. 2012 Jan;2(1):41-6
pubmed: 22585167
Commun Biol. 2020 Oct 16;3(1):578
pubmed: 33067557
Gastroenterology. 2020 Jun;158(8):2072-2081
pubmed: 32199881
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
J Clin Oncol. 2011 Sep 1;29(25):3374-80
pubmed: 21788563
Crit Rev Oncol Hematol. 2019 Jan;133:58-73
pubmed: 30661659
Gut. 2009 Jan;58(1):97-103
pubmed: 18755888
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
J Clin Oncol. 2020 Mar 1;38(7):674-685
pubmed: 31841383
Nat Commun. 2020 Aug 14;11(1):4085
pubmed: 32796935
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
Am J Gastroenterol. 2010 Jun;105(6):1258-64; author reply 1265
pubmed: 20051941
J Clin Oncol. 2017 Oct 20;35(30):3382-3390
pubmed: 28767289
Gastroenterology. 2014 Dec;147(6):1308-1316.e1
pubmed: 25194673

Auteurs

Akiyoshi Kasuga (A)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Takeshi Okamoto (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Shohei Udagawa (S)

Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Chinatsu Mori (C)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Takafumi Mie (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Takaaki Furukawa (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Yuto Yamada (Y)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Tsuyoshi Takeda (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Masato Matsuyama (M)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Takashi Sasaki (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Masato Ozaka (M)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Arisa Ueki (A)

Department of Clinical Genetics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Naoki Sasahira (N)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH